Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Arbutus Biopharma Corporation is a clinical-stage biopharmaceutical company focused on infectious disease. The Company is developing imdusiran (AB-729), its proprietary, conjugated GalNAc, subcutaneously delivered RNAi therapeutic, and AB-101, its proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV). Its HBV product pipeline includes Imdusiran and AB-101. Its pipeline includes two product candidates that target various steps in the HBV viral lifecycle and consists of various programs: RNAi therapeutic (imdusiran, AB-729) and Oral PD-L1 Inhibitor (AB-101). RNAi therapeutics utilize a natural pathway within cells to silence genes by eliminating the disease-causing proteins that they code for. PD-L1 inhibitors complement its pipeline of agents and could potentially be a part of a combination therapy for the treatment of HBV by reawakening the immune system.
Find out what a historical investment in Arbutus Biopharma Corporation would be worth today using our ABUS stock calculator.
Buying ABUS shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Arbutus Biopharma Corporation in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in ABUS
What is the ticker symbol of Arbutus Biopharma Corporation?
The ticker symbol for Arbutus Biopharma Corporation is ABUS.
How much is one share of ABUS?
One share of ABUS is valued at $4.02 as of 22 November 2026.
What is the market capitalisation of Arbutus Biopharma Corporation ABUS?
As of 22 November 2026 Arbutus Biopharma Corporation has a market cap of $616.24M.
What is the P/E ratio of ABUS?
The Price to Earnings ratio of ABUS is 3.63.
What is the Earnings Per Share of ABUS?
The Earnings Per Share of ABUS is $1.12.
What is the 52-week high for Arbutus Biopharma Corporation stock?
The Arbutus Biopharma Corporation 52-week high stock price is $5.45.
What is the 52-week low for Arbutus Biopharma Corporation stock?
The Arbutus Biopharma Corporation 52-week low stock price is $3.50.
Can I buy ABUS shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy ABUS shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in ABUS on Stake
Buy ABUS from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of ABUS from only US$10 with fractional shares